AI is a viable alternative to high throughput screening: a 318-target study
2024 · Scientific Reports · 114 citations
https://doi.org/10.1038/s41598-024-54655-z
B
Brianna C. Morten
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
28
Papers
544
Citations
14
h-index
16
i10-index
Brianna C. Morten is an academic researcher. The author has contributed to research in topics: Cancer-related Molecular Pathways & Esophageal Cancer Research and Treatment & Gastric Cancer Management and Outcomes. The author has an h-index of 14, co-authored 24 publications.
ORCID: 0000-0003-1152-8655Papers by this author
worksMortality from esophagectomy for esophageal cancer across low, middle, and high-income countries: An international cohort study
2020 · European Journal of Surgical Oncology · 34 citations
https://doi.org/10.1016/j.ejso.2020.12.006
Comparison of short-term outcomes from the International Oesophago-Gastric Anastomosis Audit (OGAA), the Esophagectomy Complications Consensus Group (ECCG), and the Dutch Upper Gastrointestinal Cancer Audit (DUCA)
2021 · BJS Open · 20 citations
https://doi.org/10.1093/bjsopen/zrab010
Alterations in the p53 isoform ratio govern breast cancer cell fate in response to DNA damage
2022 · Cell Death and Disease · 14 citations
https://doi.org/10.1038/s41419-022-05349-9
The intron 3 16 bp duplication polymorphism of p53 (rs17878362) is not associated with increased risk of developing triple-negative breast cancer
2018 · Breast Cancer Research and Treatment · 8 citations
https://doi.org/10.1007/s10549-018-5039-9
Author Correction: AI is a viable alternative to high throughput screening: a 318-target study
2024 · Scientific Reports · 1 citations
https://doi.org/10.1038/s41598-024-70321-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat